Stock SNPX SYNAPTOGENIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Synaptogenix, Inc.

Equities

SNPX

US87167T3005

Delayed Nasdaq
Other stock markets
 02:04:29 2024-07-16 pm EDT 		5-day change 1st Jan Change
4.35 USD -1.81% Intraday chart for Synaptogenix, Inc. -3.33% -36.01%
Jul. 11 Maxim Upgrades Synaptogenix to Buy From Hold, Price Target is $14 MT
Jun. 26 Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. SNPX Stock
  4. Revisions Synaptogenix, Inc.